Background: Dementia and cognitive impairment, primarily linked to aging, are increasingly recognized as multifactorial conditions. Emerging research has pointed to early menopause as another potential risk factor. However, its relationship with cognitive impairment needs further investigation, especially in low- and middle-income countries. Therefore, this study aims to analyze the effect of early menopause on cognitive impairment in the Brazilian population.

Methods: We analyzed data from the Brazilian Longitudinal Study of Aging (ELSI-Brazil), a nationally representative study of individuals older than 50 years. In this analysis, we included only women (n = 4,494) and defined early menopause as when its age of onset occurred before 45 years. A Global Cognitive Score (GCS) was computed by standardizing Z scores yielded by the assessment of four cognitive subdomains (orientation, fluency, episodic memory, and semantic memory). Depression was assessed using the Epidemiological Scale-Depression 8 (CES-D8), with scores of 3 or higher indicating depression. High cardiovascular risk (HCR) was defined by a history of stroke or heart attack. We conducted a general linear model with GCS as the dependent variable, and early menopause, age, HCR, and depression as covariates. Statistical analyses were performed in the R environment, and significance was set at p < 0.05.

Results: Of the 4,494 women included in the study, 1,218 (27.1%) had early menopause. Age between groups is not different, but the group with early menopause had fewer years of education than women with normal menopause (p < 0.001) (Table 1). Early menopause is significantly and independently associated with lower scores in GCS (β: -0.112, p <0.001), implying a lower performance in the cognitive assessment. Seemingly, depression (p < 0.001), age (p < 0.001), and high cardiovascular risk (p = 0.009) negatively impact GCS.

Conclusions: Our study shows early menopause as an independent factor associated with cognitive impairment in a representative sample of the Brazilian population. Further research is warranted to elucidate the underlying mechanisms linking early menopause to cognitive impairment and to develop effective interventions that can optimize cognitive health in this vulnerable population.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.093431DOI Listing

Publication Analysis

Top Keywords

early menopause
28
cognitive impairment
12
menopause age
12
menopause
8
early
7
cognitive
5
clinical manifestations
4
manifestations background
4
background dementia
4
dementia cognitive
4

Similar Publications

Background: Women are at increased risk for Alzheimer's disease (AD) compared to men. Given research supporting up to 40% of AD cases as preventable with lifestyle modification, midlife represents a critical time of life to intervene on dementia risks; however, little research has examined women-specific presentation of risk at midlife, or how menopause staging may impact risk presentation. The aim of this study was to assess dementia risk profiles in women at risk for AD due to family history, including self-reported and lab-based modifiable risks, and to determine the role of menopause on risk presentation.

View Article and Find Full Text PDF

Background: The increasing prevalence of neurodegenerative diseases, particularly among women post-menopause, is linked to the decline in 17 β estradiol (E2). Vitamin D deficiency, common in older individuals, exacerbates this risk due to its anti-inflammatory and neuroprotective properties. Hypovitaminosis D is associated with age-related conditions, including cognitive decline.

View Article and Find Full Text PDF

Background: More than 2/3 of Alzheimer's Disease (AD) patients are women, which has led to increased interest in the neurophysiological impact of estrogen decline during menopause. While early evidence suggested that hormone replacement therapy (HRT) may be protective against dementia, more recent studies have found inconclusive or even harmful effects.

Method: We tested the association between HRT use (estrogen or estrogen + progestin) and AD-related neuropathological outcomes measured on autopsy data in females from the National Alzheimer's Coordinating Center (NACC) (N = 3423).

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Centre for Brain Research, Indian Institute of Science, Bangalore, Karnataka, India.

Background: Studies have reported the neuroprotective role of estrogen, and that the post-menopausal state could be a risk factor for cognitive decline. However, the relationship between menopausal age and cognitive functions has not been adequately studied in the Indian population.

Method: Srinivaspura Neuro Senescence and Cognition (SANSCOG) is an ongoing rural community-based longitudinal study on aging in India.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!